DE69800092T2 - Substituierte 4-(6-fluor-[1H]-indol-3-yl)1,2,3,6-Tetrahydropyridin-Derivate für die Behandlung von ZNS-Störungen - Google Patents

Substituierte 4-(6-fluor-[1H]-indol-3-yl)1,2,3,6-Tetrahydropyridin-Derivate für die Behandlung von ZNS-Störungen

Info

Publication number
DE69800092T2
DE69800092T2 DE69800092T DE69800092T DE69800092T2 DE 69800092 T2 DE69800092 T2 DE 69800092T2 DE 69800092 T DE69800092 T DE 69800092T DE 69800092 T DE69800092 T DE 69800092T DE 69800092 T2 DE69800092 T2 DE 69800092T2
Authority
DE
Germany
Prior art keywords
indol
fluoro
substituted
treatment
cns disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69800092T
Other languages
English (en)
Other versions
DE69800092D1 (de
Inventor
John Fairhurst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co Ltd
Eli Lilly and Co
Original Assignee
Eli Lilly and Co Ltd
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co Ltd, Eli Lilly and Co filed Critical Eli Lilly and Co Ltd
Publication of DE69800092D1 publication Critical patent/DE69800092D1/de
Application granted granted Critical
Publication of DE69800092T2 publication Critical patent/DE69800092T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69800092T 1997-01-17 1998-01-14 Substituierte 4-(6-fluor-[1H]-indol-3-yl)1,2,3,6-Tetrahydropyridin-Derivate für die Behandlung von ZNS-Störungen Expired - Fee Related DE69800092T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700895.7A GB9700895D0 (en) 1997-01-17 1997-01-17 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
DE69800092D1 DE69800092D1 (de) 2000-04-20
DE69800092T2 true DE69800092T2 (de) 2000-09-14

Family

ID=10806121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69800092T Expired - Fee Related DE69800092T2 (de) 1997-01-17 1998-01-14 Substituierte 4-(6-fluor-[1H]-indol-3-yl)1,2,3,6-Tetrahydropyridin-Derivate für die Behandlung von ZNS-Störungen

Country Status (29)

Country Link
US (1) US20010053783A1 (de)
EP (1) EP0854146B1 (de)
JP (1) JPH10204090A (de)
KR (1) KR20000070221A (de)
AR (1) AR011422A1 (de)
AT (1) ATE190617T1 (de)
AU (1) AU5569298A (de)
CA (1) CA2227132A1 (de)
CZ (1) CZ290318B6 (de)
DE (1) DE69800092T2 (de)
DK (1) DK0854146T3 (de)
EA (1) EA001469B1 (de)
ES (1) ES2144888T3 (de)
GB (1) GB9700895D0 (de)
GR (1) GR3033316T3 (de)
HU (1) HUP0000854A3 (de)
ID (1) ID21920A (de)
IL (1) IL129647A (de)
NO (1) NO993372D0 (de)
NZ (1) NZ335493A (de)
PE (1) PE99399A1 (de)
PL (1) PL334569A1 (de)
PT (1) PT854146E (de)
SI (1) SI0854146T1 (de)
SV (1) SV1998000088A (de)
TR (1) TR199901583T2 (de)
TW (1) TW396156B (de)
WO (1) WO1998031686A1 (de)
ZA (1) ZA98300B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897921A1 (de) * 1997-08-22 1999-02-24 Eli Lilly And Company Limited Benzothiadiazinyl-indolderivate und ihre Verwendung als Serotoninrezeptor-liganden
GB9825413D0 (en) 1998-11-19 1999-01-13 Lilly Co Eli Pharmaceutical compounds
GB9903784D0 (en) * 1999-02-18 1999-04-14 Lilly Co Eli Pharmaceutical compounds
AR028945A1 (es) * 2000-06-19 2003-05-28 Lundbeck & Co As H Derivados de indol
KR101165996B1 (ko) 2010-04-23 2012-07-18 주식회사 녹십자 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
CN105949190B (zh) * 2016-07-04 2018-06-29 烟台凯博医药科技有限公司 一种制备1，8-萘啶及衍生物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
WO1998031686A1 (en) 1998-07-23
IL129647A0 (en) 2000-02-29
SI0854146T1 (en) 2000-10-31
PL334569A1 (en) 2000-03-13
NO993372L (no) 1999-07-08
EP0854146B1 (de) 2000-03-15
DE69800092D1 (de) 2000-04-20
GB9700895D0 (en) 1997-03-05
AR011422A1 (es) 2000-08-16
IL129647A (en) 2002-02-10
CZ151099A3 (cs) 1999-09-15
HUP0000854A3 (en) 2002-06-28
US20010053783A1 (en) 2001-12-20
CA2227132A1 (en) 1998-07-17
ATE190617T1 (de) 2000-04-15
NO993372D0 (no) 1999-07-08
EP0854146A1 (de) 1998-07-22
CZ290318B6 (cs) 2002-07-17
GR3033316T3 (en) 2000-09-29
EA199900667A1 (ru) 2000-02-28
AU5569298A (en) 1998-08-07
PT854146E (pt) 2000-08-31
ID21920A (id) 1999-08-12
ZA98300B (en) 1998-09-10
TR199901583T2 (xx) 1999-11-22
JPH10204090A (ja) 1998-08-04
KR20000070221A (ko) 2000-11-25
EA001469B1 (ru) 2001-04-23
NZ335493A (en) 2000-09-29
PE99399A1 (es) 1999-11-11
HUP0000854A2 (hu) 2000-11-28
SV1998000088A (es) 2000-10-10
ES2144888T3 (es) 2000-06-16
DK0854146T3 (da) 2000-06-05
TW396156B (en) 2000-07-01

Similar Documents

Publication Publication Date Title
DE68929540D1 (de) Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ATE304530T1 (de) Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen
ATE297917T1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
DE69825253D1 (de) Verfahren für die herstellung von 1,1,1,3,3-pentafluorpropen und 2-chlor-pentafluorpropen
TR199501132A2 (tr) Nörokinin karsitlari (antagonistleri).
DZ3027A1 (fr) Composés et procédés pour le traitement de l'asthme, de l'allergie et des troubles inflammatoires.
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
ATE260278T1 (de) 5ht1 rezeptor antagonisten und ihre verwendung für die behandlung von depression
TR28873A (tr) N-sübstitüe edilmis, N,N'-kaynasik heterosiklik benzoik asit üretmeye mahsus yöntem.
DE69622889T2 (de) Substituierte 4-(1h-benzimidazol-2-yl)(1,4)diazepane für die behandlung von allergischen krankheiten
DE69800092D1 (de) Substituierte 4-(6-fluor-[1H]-indol-3-yl)1,2,3,6-Tetrahydropyridin-Derivate für die Behandlung von ZNS-Störungen
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DE69736180D1 (de) Behandlung von manischen erkrankungen
NO20005424D0 (no) FremgangsmÕte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
FI943833A0 (fi) Menetelmä 2,3,5,6-tetraklooripyridiinin valmistamiseksi
DE60133596D1 (de) S-Methyl-Dihydro-Ziprasidone für die Behandlung von Schizophrenie
NO20005425D0 (no) FremgangsmÕte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
DE689838T1 (de) Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen
ATE357441T1 (de) Substituierte 2-pyrrolidin-2-yl-1h-indol- derivative für die behandlung von migräne
ATA33397A (de) Vorrichtung für die intravaskuläre behandlung von restenosen
NO20005351D0 (no) Paroksetin 10-kamfersulfonat for behandling av CNS lidelser
SI0874843T1 (en) Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases
ATE273287T1 (de) Verfahren und zwischenprodukte für die herstellung von herbizid wirkenden 1-(2- (cyclopropylcarbonyl)phenyl)sulfamoyl-3-(4,6- dialkoxy-2-pyrimidinyl)harnstoff-verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee